Administrative Core

行政核心

• 批准号: 10845856
• 负责人: VINEET D MENACHERY
• 金额: $ 257.77万
• 依托单位: UNIVERSITY OF TEXAS MED BR GALVESTON
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-05-16 至 2025-04-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10845856
• 关键词: Antiviral Agents; Award; Clinic; Clinical; Communication; Communities; Coronavirus; Decision Making; Development; Development Plans; Educational workshop; Ensure; Faculty; Flavivirus; Goals; Health; Henipavirus; Hybrids; Industry; Intellectual Property; Investigational Drugs; Leadership; Mentors; Modeling; Peer Review; Pharmaceutical Preparations; Postdoctoral Fellow; Prevention; Program Research Project Grants; Qualifying; Research; Research Personnel; Research Project Grants; Resource Sharing; Resources; Science; Structure; Training; Translations; United States National Institutes of Health; Viral; career; career development; clinical candidate; data sharing; design; drug candidate; drug development; drug discovery; experience; functional group; industry partner; innovation; meetings; multidisciplinary; new technology; new therapeutic target; next generation; organizational structure; pandemic disease; pandemic pathogen; pandemic potential; pandemic preparedness; preclinical development; preclinical study; prevent pandemics; programs; success; virology

ADMINISTRATIVE CORE - ABSTRACT The “UTMB-Novartis Alliance for Pandemic Preparedness (UNAPP)” combines UTMB’s excellence in virology & BSL4/3 facility with Novartis’ power in drug discovery & development to deliver pandemic antivirals. The Administrative Core provides the leadership and programmatic coordination required to fully realize the impact of this unique academic-industry partnership and meet the goals of the Antiviral Drug Discovery Centers for Pathogens of Pandemics Concern. We will accomplish this through the following four aims: i. implement an integrated organizational governance and programmatic structure that will promote a team science approach to antiviral drug discovery for pandemic prevention against Coronaviruses, Flaviviruses, and Henipaviruses; ii. provide integrated decision making in scientific, operational, financial, intellectual property protection and communication through cohesive and collaborative governance; iii. implement a Developmental Research Project program that will expand the center's scope and range of research while encouraging outside investigators to develop novel technology and innovative research ideas in antiviral drug discovery; and iv. implement a Mentored Project program designed to increase the availability of qualified early career researchers in antiviral discovery research by providing career development and mentored research to further their professional advancement.

行政核心-摘要